PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 155 filers reported holding PRECIGEN INC in Q4 2020. The put-call ratio across all filers is 1.71 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $113,497 | 0.0% | 107,073 | 0.0% | 0.00% | – |
| Q1 2023 | $113,497 | -43.8% | 107,073 | -19.4% | 0.00% | – |
| Q4 2022 | $201,982 | -99.9% | 132,883 | 0.0% | 0.00% | – |
| Q3 2022 | $281,712,000 | +22.9% | 132,883 | -22.3% | 0.00% | – |
| Q2 2022 | $229,191,000 | +11.0% | 171,038 | +74.8% | 0.00% | – |
| Q1 2022 | $206,463,000 | -43.1% | 97,850 | 0.0% | 0.00% | – |
| Q4 2021 | $363,022,000 | -25.7% | 97,850 | 0.0% | 0.00% | – |
| Q3 2021 | $488,271,000 | -23.5% | 97,850 | 0.0% | 0.00% | – |
| Q2 2021 | $637,982,000 | +3.1% | 97,850 | +8.9% | 0.00% | – |
| Q1 2021 | $618,936,000 | -21.0% | 89,831 | +16.9% | 0.00% | – |
| Q4 2020 | $783,676,000 | +154.3% | 76,831 | -12.7% | 0.00% | – |
| Q3 2020 | $308,110,000 | -29.9% | 88,031 | 0.0% | 0.00% | – |
| Q2 2020 | $439,274,000 | +35.5% | 88,031 | -7.7% | 0.00% | – |
| Q1 2020 | $324,102,000 | – | 95,324 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
| EMFO, LLC | 425,000 | $603,500 | 0.57% |
| Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
| First Washington CORP | 646,575 | $918,137 | 0.37% |
| Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
| SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
| MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
| Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
| CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |